Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Global Burden of Disease Study finds people worldwide living longer, but with more illness, disability

"A sharp decline in deaths from malnutrition and infectious diseases like measles and tuberculosis has caused a shift in global mortality patterns over the past 20 years, according to a study released on Thursday, with far more of the world's population now living into old age and dying from diseases mostly associated with rich countries, like cancer and heart disease," the New York Times reports.

15 Dec 2012

Consuming whole eggs may improve blood lipids, new research suggests

It is estimated that 34% of Americans are affected by an increasingly prevalent condition known as metabolic syndrome which is a combination of at least three of the following risk factors: large waistline, high triglycerides, low HDL cholesterol, high blood pressure and elevated blood sugar.

15 Dec 2012

Iclusig gets FDA approval for two rare blood and bone marrow diseases

The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.

15 Dec 2012

FDA grants accelerated approval to ARIAD’s Iclusig for treatment of CML, Ph+ ALL

ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.

14 Dec 2012

FDA approves Novartis Signifor injection for treatment of Cushing's disease

Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor (pasireotide) injection for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.

14 Dec 2012

ETA receptor antagonism reduces novel cardiovascular risk factors in patients with CKD

Blocking the receptor for proteins that constrict blood vessels reduces markers of heart-related problems in patients with chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

14 Dec 2012

Arginase, IDO could hold clues to help 79 million Americans with prediabetes

Two enzymes that are elevated in prediabetes could hold clues to helping the 79 million Americans with the condition avoid serious vascular complications and maybe even identify those most at risk for full-blown diabetes, researchers say.

13 Dec 2012

New way to effectively make designer drugs that hit collections of protein targets simultaneously

An international research collaboration led by scientists at the University of North Carolina School of Medicine and the University of Dundee, in the U.K., have developed a way to efficiently and effectively make designer drugs that hit multiple protein targets at once.

13 Dec 2012

Roadmap outlines steps that are necessary to improve healthcare delivery in the U.S.

Regardless of what you think about the Affordable Care Act (ACA), also called Obama Care, healthcare in the U.S. needs a major overhaul. That overhaul began with ACA, and now additional changes are going to be needed in order to make healthcare more economically sustainable in the U.S.

13 Dec 2012

Bumetanide could treat children with severe autism or Asperger's syndrome

Although this therapy is not curative, it nevertheless reduced the autistic disorders' severity in three-quarters of the children. The researchers have filed a request for authorisation to perform a multi-centre European clinical trial in order to determine more precisely the population concerned by this therapy.

13 Dec 2012

ACOEM initiative provides tools and resources to help employers address obesity

As part of its year-long campaign addressing chronic disease in the workplace, the American College of Occupational and Environmental Medicine (ACOEM) is providing tools and resources to help employers identify and respond to the impact of obesity on worker health and productivity. Such resources and tools are of special relevance at this time of the year.

13 Dec 2012

Prematurity marks the adult heart

People born preterm have compromised cardiac structure and function as young adults, a study shows.

12 Dec 2012

Kaiser Permanente suggests simple steps to improve overall health

Kaiser Permanente Southern California wants you to take a 12 minute break and think about how you're going to achieve total health this New Year to become a better you!

12 Dec 2012

Inotuzumab ozogamicin selectively destroys malignant cells responsible for ALL in weekly dosing

A potent chemotherapy agent wrapped within a monoclonal antibody selectively destroys the malignant cells responsible for acute lymphocytic leukemia (ALL) in either weekly or monthly dosing, researchers report at the 54th ASH Annual Meeting and Exposition.

12 Dec 2012

Examining Americans' health: Longer, but sicker, lives; Childhood obesity drops

A new report finds Americans may be living longer thanks to medical advances, but they may also be sicker. Meanwhile, childhood obesity may be dropping in several cities around the nation.

12 Dec 2012

Astellas, FibroGen commence FG-4592/ASP1517 Phase 3 clinical program in CKD anemia

FibroGen, Inc., and Astellas Pharma Inc., announced today the initiation of the first clinical study in the Phase 3 clinical development program of FG-4592/ASP1517, an orally administered small molecule, for treatment of anemia associated with chronic kidney disease ("CKD") in patients not on dialysis and on dialysis, to support approval in the U.S. and Europe.

12 Dec 2012

Strong association between bedroom TV viewing and childhood obesity

The average American child from age 8 to 18 watches about 4.5 hours of TV each day. Seventy percent have a TV in the bedroom and about one-third of youth aged 6-19 is considered obese.

11 Dec 2012

FDA expands approved use of Janssen Biotech’s Zytiga to treat men with mCRPC

The U.S. Food and Drug Administration today expanded the approved use of Zytiga (abiraterone acetate) to treat men with late-stage (metastatic) castration-resistant prostate cancer prior to receiving chemotherapy.

10 Dec 2012

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

Janssen announced today that the U.S. Food and Drug Administration (FDA) has approved a broader indication for the oral, once-daily medication ZYTIGA (abiraterone acetate).

10 Dec 2012

New hope for leukemia patients

Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the therapy, which was pioneered by scientists in the Perelman School of Medicine at the University of Pennsylvania

10 Dec 2012

Blood Pressure News and Research

Further Reading

Global Burden of Disease Study finds people worldwide living longer, but with more illness, disability

Consuming whole eggs may improve blood lipids, new research suggests

Iclusig gets FDA approval for two rare blood and bone marrow diseases

FDA grants accelerated approval to ARIAD’s Iclusig for treatment of CML, Ph+ ALL

FDA approves Novartis Signifor injection for treatment of Cushing's disease

ETA receptor antagonism reduces novel cardiovascular risk factors in patients with CKD

Arginase, IDO could hold clues to help 79 million Americans with prediabetes

New way to effectively make designer drugs that hit collections of protein targets simultaneously

Roadmap outlines steps that are necessary to improve healthcare delivery in the U.S.

Bumetanide could treat children with severe autism or Asperger's syndrome

ACOEM initiative provides tools and resources to help employers address obesity

Prematurity marks the adult heart

Kaiser Permanente suggests simple steps to improve overall health

Inotuzumab ozogamicin selectively destroys malignant cells responsible for ALL in weekly dosing

Examining Americans' health: Longer, but sicker, lives; Childhood obesity drops

Astellas, FibroGen commence FG-4592/ASP1517 Phase 3 clinical program in CKD anemia

Strong association between bedroom TV viewing and childhood obesity

FDA expands approved use of Janssen Biotech’s Zytiga to treat men with mCRPC

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

New hope for leukemia patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News